|
1
|
Scully C and Bagan J: Oral squamous cell
carcinoma: Overview of current understanding of aetiopathogenesis
and clinical implications. Oral Dis. 15:388–399. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weatherspoon DJ, Chattopadhyay A,
Boroumand S and Garcia I: Oral cavity and oropharyngeal cancer
incidence trends and disparities in the United States: 2000–2010.
Cancer Epidemiol. 39:497–504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ng JH, Iyer NG, Tan MH and Edgren G:
Changing epidemiology of oral squamous cell carcinoma of the
tongue: A global study. Head Neck. 39:297–304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghantous Y, Yaffi V and Abu-Elnaaj I: Oral
cavity cancer: Epidemiology and early diagnosis. Refuat Hapeh
Vehashinayim (1993). 3255–63. (71)2015.(In Hebrew). PubMed/NCBI
|
|
5
|
Hanai J, Chen LF, Kanno T, Ohtani-Fujita
N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, et al:
Interaction and functional cooperation of PEBP2/CBF with Smads.
Synergistic induction of the immunoglobulin germline Calpha
promoter. J Biol Chem. 274:31577–31582. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Subramaniam MM, Chan JY, Yeoh KG, Quek T,
Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human
carcinogenesis. Biochim Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
|
7
|
Ito Y: Oncogenic potential of the RUNX
gene family: ‘Overview’. Oncogene. 23:4198–4208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tonomoto Y, Tachibana M, Dhar DK, Onoda T,
Hata K, Ohnuma H, Tanaka T and Nagasue N: Differential expression
of RUNX genes in human esophageal squamous cell carcinoma:
Downregulation of RUNX3 worsens patient prognosis. Oncology.
73:346–356. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ito K, Liu Q, Salto-Tellez M, Yano T, Tada
K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, et al: RUNX3, a
novel tumor suppressor, is frequently inactivated in gastric cancer
by protein mislocalization. Cancer Res. 65:7743–7750. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soong R, Shah N, Peh BK, Chong PY, Ng SS,
Zeps N, Joseph D, Salto-Tellez M, Iacopetta B and Ito Y: The
expression of RUNX3 in colorectal cancer is associated with disease
stage and patient outcome. Br J Cancer. 100:676–679. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu GP, Ji Y, Chen GQ, Huang B, Shen K, Wu
S and Shen ZY: Application of RUNX3 gene promoter methylation in
the diagnosis of non-small cell lung cancer. Oncol Lett. 3:159–162.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito
K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, et al: RUNX3 is
frequently inactivated by dual mechanisms of protein
mislocalization and promoter hypermethylation in breast cancer.
Cancer Res. 66:6512–6520. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bai J, Yong HM, Chen FF, Song WB, Li C,
Liu H and Zheng JN: RUNX3 is a prognostic marker and potential
therapeutic target in human breast cancer. J Cancer Res Clin Oncol.
139:1813–1823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim BR, Kang MH, Kim JL, Na YJ, Park SH,
Lee SI, Kang S, Joung SY, Lee SY, Lee DH, et al: RUNX3 inhibits the
metastasis and angiogenesis of colorectal cancer. Oncol Rep.
36:2601–2608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen H, Wang Z, Wang S, Zhang Z and Shi S:
Effect and mechanism of RUNX3 gene on biological characteristics of
human esophageal squamous cell carcinoma (ESCC). Med Oncol.
32:3572015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mei PJ, Bai J, Liu H, Li C, Wu YP, Yu ZQ
and Zheng JN: RUNX3 expression is lost in glioma and its
restoration causes drastic suppression of tumor invasion and
migration. J Cancer Res Clin Oncol. 137:1823–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adelstein D, Gillison ML, Pfister DG,
Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ,
Cmelak AJ, et al: NCCN guidelines insights: Head and neck cancers,
version 2.2017. J Natl Compr Canc Netw. 15:761–770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou WN, Du YF, Bai J, Song XM, Zheng Y,
Yuan H, Zhang W, Zhang ZD and Wu YN: RUNX3 plays a tumor suppressor
role by inhibiting cell migration, invasion and angiogenesis in
oral squamous cell carcinoma. Oncol Rep. 38:2378–2386. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao F, Huang C, Lin M, Wang Z, Shen J,
Zhang H, Jiang L and Chen Q: Frequent inactivation of RUNX3 by
promoter hypermethylation and protein mislocalization in oral
squamous cell carcinomas. J Cancer Res Clin Oncol. 135:739–747.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Myers JN, Elkins T, Roberts D and Byers
RM: Squamous cell carcinoma of the tongue in young adults:
Increasing incidence and factors that predict treatment outcomes.
Otolaryngol Head Neck Surg. 122:44–51. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lefeuvre M, Gunduz M, Nagatsuka H, Gunduz
E, Al Sheikh Ali M, Beder L, Fukushima K, Yamanaka N, Shimizu K and
Nagai N: Fine deletion analysis of 1p36 chromosomal region in oral
squamous cell carcinomas. J Oral Pathol Med. 38:94–98. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen F, Liu X, Bai J, Pei D and Zheng J:
The emerging role of RUNX3 in cancer metastasis (Review). Oncol
Rep. 35:1227–1236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Supic G, Kozomara R, Jovic N, Zeljic K and
Magic Z: Hypermethylation of RUNX3 but not WIF1 gene and its
association with stage and nodal status of tongue cancers. Oral
Dis. 17:794–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Freitas Cordeiro-Silva M, Stur E,
Agostini LP, de Podestá JR, de Oliveira JC, Soares MS, Mendonça EF,
Gouvea SA, Von Zeidler SV and Louro ID: Promoter hypermethylation
in primary squamous cell carcinoma of the oral cavity and
oropharynx: A study of a Brazilian cohort. Mol Biol Rep.
39:10111–10119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Feng XL, Shi L, Gong CJ, He ZJ,
Wu HJ and Ling TY: Genome-wide analysis of DNA methylation in
tongue squamous cell carcinoma. Oncol Rep. 29:1819–1826. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hynes RO: Metastatic potential: Generic
predisposition of the primary tumor or rare, metastatic variants-or
both? Cell. 113:821–823. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lambert AW, Pattabiraman DR and Weinberg
RA: Emerging biological principles of metastasis. Cell.
168:670–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hedbäck N, Jensen DH, Specht L, Fiehn AM,
Therkildsen MH, Friis-Hansen L, Dabelsteen E and von Buchwald C:
MiR-21 expression in the tumor stroma of oral squamous cell
carcinoma: An independent biomarker of disease free survival. PLoS
One. 9:e951932014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shinriki S, Jono H, Ueda M, Obayashi K,
Nakamura T, Ota K, Ota T, Sueyoshi T, Guo J, Hayashi M, et al:
Stromal expression of neutrophil gelatinase-associated lipocalin
correlates with poor differentiation and adverse prognosis in oral
squamous cell carcinoma. Histopathology. 64:356–364. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kudo Y, Tsunematsu T and Takata T:
Oncogenic role of RUNX3 in head and neck cancer. J Cell Biochem.
112:387–393. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsunematsu T, Kudo Y, Iizuka S, Ogawa I,
Fujita T, Kurihara H, Abiko Y and Takata T: RUNX3 has an oncogenic
role in head and neck cancer. PLoS One. 4:e58922009. View Article : Google Scholar : PubMed/NCBI
|
